Lidocaine Injection Recall Due to Hair Contamination
Fresenius Kabi is recalling lidocaine injection vials after hair was found in the product. The recall affects 181,225 vials distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving a sterile injectable drug with particulate contamination (hair), which poses a risk of harm if administered to patients. No illnesses or injuries have been reported at this time, so the score is capped at 3 per the rubric.
Plain-English summary
Fresenius Kabi USA, LLC is recalling Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL, sold in 25 single-dose vials per tray. The product is being recalled due to the presence of particulate matter, specifically hair found in the product.
The recalled product
- Product
- LIDOCAINE (LIDOCAINE HYDROCHLORIDE)
- Brand
- LIDOCAINE
- Manufacturer
- Fresenius Kabi USA, LLC
- Category
- Drug — Injectable / Sterile
- Hazard
- particulate-contamination
- foreign-matter
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 6133801
- Exp. Date 01/2028
UPCs (1)
- 0363323208011
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LIDOCAINE
- ModerateLidocaine and epinephrine dental cartridges recalled over cracked containers
FDA (Drugs) · 2025-12-24
- ModerateLidocaine Patch 5% Recalled for Typographical Error on Label
FDA (Drugs) · 2023-05-10
- ModeratePrescription Lidocaine Patches Recalled for Temperature-Related Quality Deviations
FDA (Drugs) · 2022-06-15
- ModerateFDA Recalls Prescription Lidocaine Patch Due to Temperature Exposure
FDA (Drugs) · 2022-06-15
Same category
- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighNaropin Injection Recall Over Particulate Matter Contamination
FDA (Drugs) · 2026-07-29
- ModerateFDA Recalls Xylocaine Injections Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateCyproheptadine Hydrochloride Syrup Recall Due to Precipitate
FDA (Drugs) · 2026-07-29
- HighXylocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29